Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

6.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

2.6K
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Medial Posterior Ciliary Artery Occlusion after Facial HA-CaHA Injection.

Ophthalmology·2026
Same author

Deep learning model for real time moisture content detection and prediction in white tea withering using near infrared spectroscopy.

Scientific reports·2026
Same author

Hypoxia-preconditioned adipose-derived stem cells with injectable small intestinal submucosa for enhanced cartilage repair in osteoarthritis.

Bioengineering & translational medicine·2026
Same author

In situ remediation of per- and polyfluoroalkyl substances by colloidal activated carbon in groundwater and vadose zone.

Journal of hazardous materials·2026
Same author

Dietary acrylamide exposure increases susceptibility to ulcerative colitis: A comprehensive analysis from network toxicology to in vivo experimental validation.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2026
Same author

Efficient combined use of electroacupuncture with ordered collagen scaffolds enhances the therapeutic efficacy of human spinal cord-derived neural progenitor cells therapy in spinal cord injury rats.

Science China. Life sciences·2026
Same journal

Long-term control of peritoneal metastases following claudin 18.2-targeted CAR T-Cell therapy in advanced gastric cancer.

Journal of hematology & oncology·2026
Same journal

Vibecotamab for measurable residual disease in acute myeloid leukemia and for myelodysplastic syndromes and chronic myelomonocytic leukemia after hypomethylating agent failure: a phase II study.

Journal of hematology & oncology·2026
Same journal

The DAPK3-DCAF1 pathway regulates ZBP1 protein stability to orchestrate PANoptosis for ovarian cancer therapy.

Journal of hematology & oncology·2026
Same journal

Outcomes and prognostic factors in patients with systemic mastocytosis and an associated myeloid neoplasm: an international ECNM registry study.

Journal of hematology & oncology·2026
Same journal

BTKi orelabrutinib improved the outcome of newly-diagnosed PCNS-LBCL by alleviating MyD88<sup>L265P</sup>-induced PIM1 stability.

Journal of hematology & oncology·2026
Same journal

Cancer-associated fibroblasts and tertiary lymphoid structure orchestrate the spatial architecture of tumor immunity.

Journal of hematology & oncology·2026
See all related articles

Related Experiment Video

Updated: Apr 26, 2026

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis
03:53

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis

Published on: December 29, 2023

1.4K

Tissue factor in tumor microenvironment: a systematic review.

Xiao Han, Bo Guo, Yongsheng Li

    Journal of Hematology & Oncology
    |August 3, 2014
    PubMed
    Summary
    This summary is machine-generated.

    Aberrant hemostasis in cancer patients often leads to venous thromboembolism (VTE), a major cause of mortality. Tissue factor (TF) plays a key role in initiating coagulation and thrombosis, contributing to tumor progression and VTE risk.

    More Related Videos

    Tissue Engineering of Tumor Stromal Microenvironment with Application to Cancer Cell Invasion
    05:48

    Tissue Engineering of Tumor Stromal Microenvironment with Application to Cancer Cell Invasion

    Published on: March 18, 2014

    9.2K
    A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication
    09:52

    A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication

    Published on: September 20, 2016

    9.4K

    Related Experiment Videos

    Last Updated: Apr 26, 2026

    Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis
    03:53

    Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis

    Published on: December 29, 2023

    1.4K
    Tissue Engineering of Tumor Stromal Microenvironment with Application to Cancer Cell Invasion
    05:48

    Tissue Engineering of Tumor Stromal Microenvironment with Application to Cancer Cell Invasion

    Published on: March 18, 2014

    9.2K
    A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication
    09:52

    A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication

    Published on: September 20, 2016

    9.4K

    Area of Science:

    • Oncology
    • Hematology
    • Molecular Biology

    Background:

    • Aberrant hemostasis is a frequent complication in cancer patients.
    • Venous thromboembolism (VTE) is the second leading cause of mortality in cancer patients.
    • Tissue factor (TF) is implicated in both coagulation initiation and tumor progression.

    Purpose of the Study:

    • To review the regulation and roles of Tissue Factor (TF) in cancer.
    • To explore TF's contribution to tumor progression and clinical complications like VTE.

    Main Methods:

    • Review of laboratory and clinical evidence.
    • Analysis of TF expression and function in various cancer systems.
    • Correlation of TF-positive microparticles (TF+MP) with VTE rates.

    Main Results:

    • TF is aberrantly expressed in multiple cancer types, promoting tumor growth.
    • TF influences myeloid cell recruitment and tumor microenvironment remodeling.
    • Elevated TF-positive microparticles (TF+MP) correlate with increased VTE risk in cancer patients.

    Conclusions:

    • TF is a critical factor in cancer-associated thrombosis and tumor progression.
    • Understanding TF regulation is crucial for managing cancer complications.
    • TF and TF+MP represent potential therapeutic targets for cancer patients at risk of VTE.